Licensed Bulk Medicines

Tender description

We are interested in buying the following list of products, in licensed bulk containers of up to the sizes noted below, to be available within a 5 year timeframe. We consider the availability in licensed bulk presentation to be a significant market advantage and are willing to consider entering contracts for supply with suppliers who can meet this presentation requirement for these products. Estimated value in the Wales market of this list is £42,317,736.61 p/a at current prices. The list is not exhaustive, and we are willing to consider other generic and biosimilar products if licensed bulk presentation can be offered. Drug,Strength,Proposed Vial Size ARSENIC TRIOXIDE,1mg/mL, AZACITIDINE,25mg/mL,500mL BEVACIZUMAB,25mg/mL,100mL - 250mL BORTEZOMIB,2.5mg/mL,50mL CALCIUM FOLINATE,10mg/mL,1000mL CARBOPLATIN,10mg/mL,1000mL CETUXIMAB,5mg/mL,250m – 500mL CISPLATIN,1mg/mL,500mL - 1000mL CYCLOPHOSPHAMIDE,20mg/mL,500mL CYTARABINE,100mg/mL or 20mg/mL,250mL DARATUMUMAB,20mg/mL,100mL – 250mL DOCETAXEL,20mg/mL,250mL - 500mL DOXORUBICIN,2mg/mL,1000mL EPIRUBICIN,2mg/mL,1000mL ETOPOSIDE,20mg/mL,500mL FLUCLOXACILLIN,,3000mL FLUOROURACIL,50mg/mL or 25mg /mL,250-500mL INFLIXIMAB,10mg/mL,500mL - 1000mL IRINOTECAN,20mg/mL,1000mL NIVOLUMAB,10mg/mL,250mL OXALIPLATIN,5mg/mL,500mL-1000mL PACLITAXEL,6mg/mL,1000mL PEMBROLIZUMAB,25mg/mL,100mL – 250mL PEMETREXED,25mg/mL,100mL – 250mL PIPERACILLIN & TAZOBACTAM,,3000mL RITUXIMAB,10mg/mL,500mL TOCILIZUMAB,20mg/mL,250mL TRASTUZUMAB EMTANSINE,20mg/mL,100mL - 250mL VEDOLIZUMAB,60mg/mL,250mL VITLIPID N INFANT,N/A,250mL Please inform us via the contact information above if you are able to provide these products. Lot 1: We are interested in buying the following list of products, in licensed bulk containers of up to the sizes noted below, to be available within a 5 year timeframe. We consider the availability in licensed bulk presentation to be a significant market advantage and are willing to consider entering contracts for supply with suppliers who can meet this presentation requirement for these products. Estimated value in the Wales market of this list is £42,317,736.61 p/a at current prices. The list is not exhaustive, and we are willing to consider other generic and biosimilar products if licensed bulk presentation can be offered. Drug,Strength,Proposed Vial Size ARSENIC TRIOXIDE,1mg/mL, AZACITIDINE,25mg/mL,500mL BEVACIZUMAB,25mg/mL,100mL - 250mL BORTEZOMIB,2.5mg/mL,50mL CALCIUM FOLINATE,10mg/mL,1000mL CARBOPLATIN,10mg/mL,1000mL CETUXIMAB,5mg/mL,250m – 500mL CISPLATIN,1mg/mL,500mL - 1000mL CYCLOPHOSPHAMIDE,20mg/mL,500mL CYTARABINE,100mg/mL or 20mg/mL,250mL DARATUMUMAB,20mg/mL,100mL – 250mL DOCETAXEL,20mg/mL,250mL - 500mL DOXORUBICIN,2mg/mL,1000mL EPIRUBICIN,2mg/mL,1000mL ETOPOSIDE,20mg/mL,500mL FLUCLOXACILLIN,,3000mL FLUOROURACIL,50mg/mL or 25mg /mL,250-500mL INFLIXIMAB,10mg/mL,500mL - 1000mL IRINOTECAN,20mg/mL,1000mL NIVOLUMAB,10mg/mL,250mL OXALIPLATIN,5mg/mL,500mL-1000mL PACLITAXEL,6mg/mL,1000mL PEMBROLIZUMAB,25mg/mL,100mL – 250mL PEMETREXED,25mg/mL,100mL – 250mL PIPERACILLIN & TAZOBACTAM,,3000mL RITUXIMAB,10mg/mL,500mL TOCILIZUMAB,20mg/mL,250mL TRASTUZUMAB EMTANSINE,20mg/mL,100mL - 250mL VEDOLIZUMAB,60mg/mL,250mL VITLIPID N INFANT,N/A,250mL Please inform us via the contact information above if you are able to provide these products.